EZH2 and prostate carcinoma: In benign prostate epithelial cells, EZH2 is expressed at low levels in the cytoplasm but becomes overexpressed in prostate cancer cells, in which its putative function is regulation of actin polymerisation (Su et al, 2005; Bryant et al, 2008).